Lipopolysaccharide induces adipose differentiation-related protein expression and lipid accumulation in the liver through inhibition of fatty acid oxidation in mice

Journal of Gastroenterology

Volumn 42, Issue 12, 2007, Pages 969-978

  Ohhira, Masumi ^a   Motomura, Wataru ^a   Fukuda, Mitsuko ^a   Yoshizaki, Takayuki ^a   Takahashi, Nobuhiko ^a   Tanno, Satoshi ^a   Wakamiya, Nobutaka ^a   Kohgo, Yutaka ^a   Kumei, Shima ^a   Okumura, Toshikatsu ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Adipose differentiation related protein; Fatty acid oxidation; Liver steatosis; LPS; PPAR

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DEHYDROGENASE; ACYL COENZYME A DESATURASE; ADIPOPHILIN; CARNITINE PALMITOYLTRANSFERASE; ENOYL COENZYME A HYDRATASE; FATTY ACID SYNTHASE; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOWN REGULATION; ENZYME INHIBITION; FATTY ACID OXIDATION; FATTY LIVER; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; LIPID STORAGE; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DIFFERENTIATION;

ANIMALS; LIPID METABOLISM; LIPOPOLYSACCHARIDES; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; PPAR ALPHA; UP-REGULATION;

EID: 37549007163     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-007-2119-8     Document Type: Article

References (47)

1. W Khovidhunkit MS Kim RA Memon JK Shigenaga AH Moser KR Feingold 2004 Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host J Lipid Res 45 1169-96 15102878 10.1194/jlr.R300019-JLR200 1:CAS:528:DC%2BD2cXltFyqs78%3D
2. JI Gallin D Kaye WM O'Leary 1969 Serum lipids in infection N Engl J Med 281 1081-6 5824173 1:STN:280:CS%2BD3cvhtVI%3D
3. K Sammalkorpi V Valtonen Y Kerttula E Nikkila MR Taskinen 1988 Changes in serum lipoprotein pattern induced by acute infections Metabolism 37 859-65 3419323 10.1016/0026-0495(88)90120-5 1:STN:280:BieA3svisFQ%3D
4. C Grunfeld M Pang W Doerrler JK Shigenaga P Jensen KR Feingold 1992 Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome J Clin Endocrinol Metab 74 1045-52 1373735 10.1210/jc.74.5.1045 1:STN:280:By2B3sritFQ%3D
5. KR Feingold I Staprans RA Memon AH Moser JK Shigenaga W Doerrler 1992 Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: Low doses stimulate hepatic triglyceride production while high doses inhibit clearance J Lipid Res 33 1765-76 1479286 1:CAS:528:DyaK3sXltl2mtQ%3D%3D
6. M Inoue T Ohtake W Motomura N Takahashi Y Hosoki S Miyoshi 2005 Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice Biochem Biophys Res Commun 336 215-22 16125673 10.1016/ j.bbrc.2005.08.070 1:CAS:528:DC%2BD2MXpvFeiu7c%3D
7. W Motomura M Inoue T Ohtake N Takahashi M Nagamine S Tanno 2006 Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet Biochem Biophys Res Commun 340 1111-8 16403437 10.1016/j.bbrc.2005.12.121 1:CAS:528:DC%2BD28XmsVClsw%3D%3D
8. JK Reddy MS Rao 2006 Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation Am J Physiol Gastrointest Liver Physiol 290 G852-8 16603729 10.1152/ajpgi.00521.2005 1:CAS:528:DC%2BD28XkvFKls7k%3D
9. L Elander L Engstrom M Hallbeck A Blomqvist 2007 IL-1beta and LPS induce anorexia by distinct mechanisms differentially dependent on microsomal prostaglandin E synthase-1 Am J Physiol Regul Integr Comp Physiol 292 R258-67 16946079 1:CAS:528:DC%2BD2sXisFGiur0%3D
10. JE Holmes NE Miller 1963 Effects of bacterial endotoxin on water intake, food intake, and body temperature in the albino rat J Exp Med 118 649-58 14067912 10.1084/jem.118.4.649 1:STN:280:CCuD38rlsVA%3D
11. A Uehara C Sekiya Y Takasugi M Namiki A Arimura 1989 Anorexia induced by interleukin 1: Involvement of corticotropin-releasing factor Am J Physiol 257 R613-7 2789477 1:CAS:528:DyaL1MXlslaiurY%3D
12. LA Adams P Angulo KD Lindor 2005 Nonalcoholic fatty liver disease CMAJ 172 899-905 15795412
13. HW Heid R Moll I Schwetlick HR Rackwitz TW Keenan 1998 Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases Cell Tissue Res 294 309-21 9799447 10.1007/s004410051181 1:CAS:528:DyaK1cXmt1Oju7g%3D
14. DL Brasaemle T Barber NE Wolins G Serrero EJ Blanchette-Mackie C Londos 1997 Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein J Lipid Res 38 2249-63 9392423 1:CAS:528:DyaK2sXnsFGqtr0%3D
15. P Targett-Adams PD Chambers S Gledhill RG Hope JF Coy A Girod 2003 Live cell analysis and targeting of the lipid droplet-binding protein adipocyte differentiation-related protein J Biol Chem 278 15998-6007 12591929 10.1074/jbc.M211289200 1:CAS:528:DC%2BD3sXjt1ehsbo%3D
16. X Wang TJ Reape X Li K Rayner CL Webb KG Burnand 1999 Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low-density lipoprotein and in atherosclerotic lesions FEBS Lett 462 145-50 10580108 10.1016/S0014-5793(99)01521-5 1:CAS:528:DyaK1MXnsVKlsL0%3D
17. D Seth MA Leo PH McGuinness CS Lieber Y Brennan R Williams 2003 Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver Am J Pathol 163 2303-17 14633604 1:CAS:528:DC%2BD2cXkslGr
18. Y Imai GM Varela MB Jackson MJ Graham RM Crooke RS Ahima 2007 Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide Gastroenterology 132 1947-54 17484887 10.1053/j.gastro.2007.02.046 1:CAS:528:DC%2BD2sXmsVymsLc%3D
19. BH Chang L Li A Paul S Taniguchi V Nannegari WC Heird 2006 Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein Mol Cell Biol 26 1063-76 16428458 10.1128/MCB.26.3.1063-1076.2006 1:CAS:528:DC%2BD28XhtVOns7w%3D
20. RA Memon LH Tecott K Nonogaki A Beigneux AH Moser C Grunfeld 2000 Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: Troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice Endocrinology 141 4021-31 11089532 10.1210/ en.141.11.4021 1:CAS:528:DC%2BD3cXnslKhurw%3D
21. R Rahimian E Masih-Khan M Lo C van Breemen BM McManus GP Dube 2001 Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus Mol Cell Biochem 224 29-37 11693197 10.1023/A:1011927113563 1:CAS:528:DC%2BD3MXot1Citbg%3D
22. L Chao B Marcus-Samuels MM Mason J Moitra C Vinson E Arioglu 2000 Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones J Clin Invest 106 1221-8 11086023 1:CAS:528:DC%2BD3cXotlChu74%3D
23. CF Burant S Sreenan K Hirano TA Tai J Lohmiller J Lukens 1997 Troglitazone action is independent of adipose tissue J Clin Invest 100 2900-8 9389757 1:CAS:528:DyaK2sXotVejt7g%3D
24. M Bedoucha E Atzpodien UA Boelsterli 2001 Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones J Hepatol 35 17-23 11495036 10.1016/S0168-8278(01)00066-6 1:CAS:528:DC%2BD3MXmtVyls7g%3D
25. K Matsusue M Haluzik G Lambert SH Yim O Gavrilova JM Ward 2003 Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes J Clin Invest 111 737-47 12618528 10.1172/JCI200317223 1:CAS:528:DC%2BD3sXhvFenurY%3D
26. S Yu K Matsusue P Kashireddy WQ Cao V Yeldandi AV Yeldandi 2003 Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression J Biol Chem 278 498-505 12401792 10.1074/ jbc.M210062200 1:CAS:528:DC%2BD38XpvVWgu7g%3D
27. J Matsui Y Terauchi N Kubota I Takamoto K Eto T Yamashita 2004 Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet Diabetes 53 2844-54 15504964 10.2337/diabetes.53.11.2844 1:CAS:528:DC%2BD2cXpvV2it7Y%3D
28. AP Beigneux AH Moser JK Shigenaga C Grunfeld KR Feingold 2000 The acute phase response is associated with retinoid X receptor repression in rodent liver J Biol Chem 275 16390-9 10747970 10.1074/jbc.M000953200 1:CAS:528:DC%2BD3cXjvFaiurY%3D
29. MS Rao JK Reddy 2004 PPARalpha in the pathogenesis of fatty liver disease Hepatology 40 783-6 15382158 10.1002/hep.20453 1:CAS:528:DC%2BD2cXptV2qtrg%3D
30. RM Evans GD Barish YX Wang 2004 PPARs and the complex journey to obesity Nat Med 10 355-61 15057233 10.1038/nm1025 1:CAS:528:DC%2BD2cXis1ektLk%3D
31. JK Reddy T Hashimoto 2001 Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: An adaptive metabolic system Annu Rev Nutr 21 193-230 11375435 10.1146/annurev.nutr.21.1.193 1:CAS:528:DC%2BD3MXlvFyku78%3D
32. T Hashimoto WS Cook C Qi AV Yeldandi JK Reddy MS Rao 2000 Defect in peroxisome proliferator-activated receptor-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting J Biol Chem 275 28918-28 10844002 10.1074/jbc.M910350199 1:CAS:528:DC%2BD3cXms1Cqt74%3D
33. S Kersten J Seydoux JM Peters FJ Gonzalez B Desvergne W Wahli 1999 Peroxisome proliferator-activated receptor mediates the adaptive response to fasting J Clin Invest 103 1489-98 10359558 1:CAS:528:DyaK1MXjvVSntLo%3D
34. MS Rao JK Reddy 2004 PPARalpha in the pathogenesis of fatty liver disease Hepatology 40 783-6 15382158 10.1002/hep.20453 1:CAS:528:DC%2BD2cXptV2qtrg%3D
35. MS Rao P Kashireddy S Musunuri A Okonkwo 2002 Prevention/reversal of CholIne deficiency-Induced steatohepatitis by a peroxisome proliferator activated receptor ligand In rats In Vivo 16 145-52 12073774 1:CAS:528:DC%2BD38XltF2qsrc%3D
36. E Ip P Hall G Robertson I Leclercq 2004 Administration of the potent PPAR agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice Hepatology 39 1286-96 15122757 10.1002/hep.20170 1:CAS:528:DC%2BD2cXks1SjtL0%3D
37. ES Tai A bin Ali Q Zhang LM Loh CE Tan L Retnam 2003 Hepatic expression of PPARalpha, a molecular target of fibrates, is regulated during inflammation in a gender-specific manner FEBS Lett 546 237-40 12832047 10.1016/S0014-5793(03)00578-7 1:CAS:528:DC%2BD3sXkvVKjtr8%3D
38. M Leid P Kastner R Lyons H Nakshatri M Saunders T Zacharewski 1992 Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently Cell 68 377-95 1310259 10.1016/0092-8674(92)90478-U 1:CAS:528:DyaK3sXhvVelsLc%3D
39. DJ Mangelsdorf U Borgmeyer RA Heyman JY Zhou ES Ong AE Oro 1992 Characterization of three RXR genes that mediate the action of 9-cis retinoic acid Genes Dev 6 329-44 1312497 10.1101/gad.6.3.329 1:CAS:528:DyaK3sXhvVelsb0%3D
40. RR Wolfe JH Shaw MJ Durkot 1985 Effect of sepsis on VLDL kinetics: responses in basal state and during glucose infusion Am J Physiol 248 E732-40 3890559 1:CAS:528:DyaL2MXksFaju70%3D
41. S Lanza-Jacoby A Tabares 1990 Triglyceride kinetics, tissue lipoprotein lipase, and liver lipogenesis in septic rats Am J Physiol 258 E678-85 2185649 1:CAS:528:DyaK3cXkt1Wmtbk%3D
42. RW Wannemacher Jr JG Pace RA Beall RE Dinterman VJ Petrella HA Neufeld 1979 Role of the liver in regulation of ketone body production during sepsis J Clin Invest 64 1565-72 500825 1:CAS:528:DyaL3cXntlOktA%3D%3D
43. M You DW Crabb 2004 Recent advances in alcoholic liver disease II. Mini-review: Molecular mechanisms of alcoholic fatty liver Am J Physiol 287 G1-6 10.1152/ajpcell.00559.2003 1:CAS:528:DC%2BD2cXlvFOhu7o%3D
44. KR Feingold S Adi I Staprans AH Moser R Neese JA Verdier 1990 Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production Am J Physiol 25 E177-84
45. L Mela LV Bacalzo Jr LD Miller 1971 Defective oxidative metabolism of rat liver mitochondria in hemorrhagic and endotoxin shock Am J Physiol 220 571-7 4250607 1:CAS:528:DyaE3MXosFeqsQ%3D%3D
46. SP Kantrow DE Taylor MS Carraway CA Piantadosi 1997 Oxidative metabolism in rat hepatocytes and mitochondria during sepsis Arch Biochem Biophys 345 278-88 9308900 10.1006/abbi.1997.0264 1:CAS:528:DyaK2sXmtVOit7g%3D
47. ED Crouser MW Julian JE Huff MS Joshi JA Bauer ME Gadd 2004 Abnormal permeability of inner and outer mitochondrial membranes contributes independently to mitochondrial dysfunction in the liver during acute endotoxemia Crit Care Med 32 478-88 14758167 10.1097/ 01.CCM.0000109449.99160.81 1:CAS:528:DC%2BD2cXos1GisQ%3D%3D